People are urging countries to avoid excessive regulation of e-cigarettes, as a new report suggests this could pose greater risks to public health in the long run. According to a report released today by UK think tank IEA, low-risk nicotine products such as heated tobacco have already led to a steep decline in smokers in some countries including the UK. The think tank refutes arguments made by anti-smoking campaigners that using smoking alternatives is dangerous for those who have quit smoking.
In fact, the UK think tank, IEA, has pointed out that according to data from the English Public Health Agency, vaping is "about 95% safer than smoking." This point has also been endorsed by the UK Cancer Research Center, which acknowledges that e-cigarettes are "far closer in harm to other nicotine replacement therapy (NRT) products.
The key point of the report is that countries should avoid overly cautious approaches and direct bans, such as the requirement for a prescription to use nicotine e-cigarette products in Australia. Essentially, the argument is not that new products should not be regulated at all, but that risks, whether direct or indirect, should be evaluated in a more balanced manner.
This news comes after US regulators banned the sale of Myblu electronic cigarettes, which are owned by Imperial Brands. The ban was imposed as a result of a review, which found inadequate evidence to support the claim that smoking bans protect public health.
Source: City AM
A think tank has issued a warning stating that banning e-cigarettes could cause more harm than good.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
